Skip to main content

Community-based Seed System Initiative thrives in Nepal

The Seed System Initiative, implemented by Cornell’s Delivering Genetic Gain in Wheat project in 2017-18, benefits wheat farmers in Nepal.

Study reveals how promising cancer drug works for best use

A study describes for the first time how a promising FDA-approved cancer drug – currently in clinical trials – works to effectively kill cancer cells. 

Immunology symposium unites Ithaca, New York City scientists

Cornell experts from Ithaca and New York City gathered June 26-27 at the College of Veterinary Medicine for the Immunology in Health and Disease Symposium.

Atkinson's Academic Venture Fund awards $1.5M to 12 projects

The Atkinson Center for a Sustainable Future’s Academic Venture Fund has awarded $1.5 million to a range of projects that will provide sustainable solutions around the world, from the Finger Lakes to the Pamir Mountains in Central Asia.

Scholars train for research in real-world settings

Thirty-three researchers from across the globe visited the Bronfenbrenner Center for Translational Research last month to learn how to conduct research through community partnerships that will inform real-world practices and decisions.

Lab-grown tumors provide insights on rare prostate cancer

Growing miniature tumors from a patient’s cells in the laboratory may help scientists personalize treatments for those with a rare form of prostate cancer, according a study by Weill Cornell Medicine and NewYork-Presbyterian scientists.

Low-carb, high-fat diet may boost targeted cancer therapy

A very low carbohydrate, high-fat diet called the ketogenic diet may improve the effectiveness of an emerging class of cancer drugs, according to a new study.

A simpler, safer operation for treating kidney cancer

Researchers at Weill Cornell Medicine and NewYork-Presbyterian/Weill Cornell Medical Center propose a simpler, safer procedure for treating a certain type of early-stage kidney cancer in older adults. 

Wildeman takes helm at Bronfenbrenner Center

Christopher Wildeman, a leading scholar on mass incarceration and child maltreatment, will become director of the Bronfenbrenner Center for Translational Research as of July 1.